Symbicom AB
Records under this name other than patents Symbicom AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Symbicom AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,083,722 | Borrelia antigen Term ended Term ended Jul 4, 2017 · From the USPTO record | Term ended | Term ended Jul 4, 2017 | From the USPTO record |
| US 6,068,842 | 66 kDa antigen from Borrelia Term ended Term ended May 30, 2017 · From the USPTO record | Term ended | Term ended May 30, 2017 | From the USPTO record |
| US 6,054,296 | 66 kDa antigen from Borrelia Term ended Term ended Apr 25, 2017 · From the USPTO record | Term ended | Term ended Apr 25, 2017 | From the USPTO record |
| US 6,090,586 | 66 kDa antigen from Borrelia Lapsed on the fee record Ended Jul 18, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jul 18, 2012 | From the USPTO record |
| US 4,859,769 | Antiviral agents Term ended Term ended no later than Aug 22, 2009 · Low confidence | Term ended | Term ended no later than Aug 22, 2009 | Low confidence |
| US 5,637,569 | Ganglioside analogs Formerly held Term ended Term ended no later than Jun 10, 2017 · Low confidence | Term ended | Term ended no later than Jun 10, 2017 | Low confidence |
| US 5,804,198 | Vaccines against disease caused by pathogenic pilus-forming bacteria Term ended Term ended no later than Sep 8, 2018 · Low confidence | Term ended | Term ended no later than Sep 8, 2018 | Low confidence |